Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Aug 16, 2021; 13(8): 275-295
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.275
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.275
Variables | Sensitivity | Specificity | PPV | NPV | Accuracy |
Morphological pattern1 | |||||
0-IIa G | 5.7% | 70.0% | 1.7% | 89.1% | 64.6% |
0-Is G | 11.5% | 83.2% | 5.8% | 91.2% | 77.3% |
0-IIa + Is G | 22.9% | 77.4% | 8.4% | 91.7% | 72.8% |
0-IIa NG | 27.4% | 79.5% | 10.8% | 92.4% | 75.2% |
0-Is NG | 16.6% | 95.5% | 25.0% | 92.7% | 89.0% |
0-IIa + Is NG | 15.9% | 94.5% | 20.7% | 92.6% | 88.0% |
Kudo pit pattern (NBI)2 | 73.3%-93.7%3 | 89.2%-100%3 | 93.7%-100%3 | 89.2%-96.4%3 | 92.0%-96.7%3 |
NICE classification4 | |||||
Type 1 | 82.1%-84.6% | 93.8%-94.9% | 65.9%-92.5% | 60.4-98.2% | 93.9%-97.8% |
Type 2 | 89.8%-91.4% | 84.3%-86.3% | 89.1%-90.7% | 97.3-97.7% | 56.6%-61.2% |
Type 3 | 83.3%-91.7% | 96.4%-97.0% | 96.0%-96.8% | 45.8-54.0% | 99.4%-99.7% |
JNET classification5 | |||||
Type 1 | 73.0%-87.1% | 96.0%-99.5% | 73.4%-92.3% | 96%-98.9% | 93.0%-98.5% |
Type 2A | 82.5%-96.0% | 70.0%-91.1% | 90.3%-96.7% | 62.1%-92.1% | 84.5%-90.9% |
Type 2B | 42.0%-75.6% | 84.2%-95.0% | 26.0%-67.3% | 92.2%-98.0% | 81.3%-93.0% |
Type 3 | 35.0%-91.7% | 98.1%-100% | 63.2%-100% | 93.8%-99.7% | 94.0%-98.0% |
Ref. | Study | Nations | N patients/les | Type of colorectal lesions | Lesion size | Procedural time1 | En bloc resection1 | R01 | Perforation1 | Bleeding1 | Surgery1 | Recurrence1 | |
Zhong et al[134], 2013 | Systematic review with meta-analysis of 4 retrospective studies | Japan, Korea, China | 243 patients/245 lesions (EMR: 106; ESD: 139) | Sessile (carcinoids) | < 15 mm | 19.1 ± 11.1 vs 8.1 ± 9.4 | 92% vs 100% | 69.1% vs 87.7% | 2.8% vs 0.7% | 2.8% vs 3.6% | 0.7% vs 0% | 2.9% vs 0% | |
Wang et al[135], 2014 | Meta-analysis of 6 studies (case-control) | Japan, Korea | 893 patients/1642 lesions (EMR: 866; ESD: 776) | Sessile or flat | ≥ 10 mm | Range, 29.0-29.4 vs 87.2-108.0 min | 44.5% vs 87.9% | 65.5% vs 83.8% | 5.8% vs 8.9% (overall complications) | NA | 12.70% vs 0.98% | ||
Wang et al[136], 2016 | Systematic review with meta-analysis of 4 retrospective studies | Brazil, Korea, Japan, China | 216 patients/216 lesions (EMR: 109; ESD: 107) | Rectal carcinoids (lesion morphology not specified) | ≥ 10 mm | (150.0 ± 66.3/116.0 ± 58.5 ± 3.6/63.0 ± 54.0/50.0 ± 589.2) vs (133.0 ± 94.8/84.0 ± 51.2/131.0 ± 100.0/78 ± 176.7) min | 93.6% vs 90.6% | 78% vs 79.4% | 10.3% vs 18.3% (overall complications) | NA | 6.4% vs 0.9% | ||
Chao et al[137], 2016 | Meta-analysis of 17 studies (retrospective) | China | 2003 patients/2003 lesions (EMR: 1054; ESD: 949) | Sessile: carcinoids (11 studies) or carcinomas (5 studies); LST (1 study) | ≥ 5 mm | Range, 15.0-65.9 vs 3.5-29.4 min | 89.8% vs 92.0% | 61.4% vs 86.5% | 1.5% vs 5.9 % | 3.3% vs 3.7% | NA | 9.9% vs 1.0% | |
Fujiya et al[103], 2015 | Meta-analysis of 8 studies (non-randomized, 6 cohort and 2 case-control) | Japan | 1262 patients (EMR: 634; ESD: 628)/1763 lesions (EMR: 949; ESD: 814) | Morphological features of lesions in 7 studies were2, in the EMR group: 0-I (269 cases) and 0-II (679 cases); in the ESD group: 0-I (125 cases) and 0-II (680 cases); 576 adenomas and 380 carcinomas | ≥ 20 mm (5 studies), ≥ 10 mm (1 study), > 5 mm (1 study) | Range, 29.0-30.0 vs 65.9-108.0 min | 46.7% vs 91.7% | 42.3% vs 80.3% | 0% vs 8.5% | 3.5% vs 2.0% | 5.8% vs 9.9% | 12.2% vs 0.9% | |
Arezzo et al[138], 2016 | Systematic review with meta-analysis of 11 studies (10 retrospective and 1 case-control) | Japan, Korea, France | 4678 patients/4678 lesions (EMR: 3161; ESD: 1517) | Sessile (LST-NG and LST-G were also included in 3 studies): adenomas, carcinomas in situ, invasive cancers or carcinoids | ≥ 20 mm (except in 3 studies) | 29.1 vs 66.5 min | 34.9% vs 89.9% | 36.2% vs 79.6% | 0.9% vs 4.9% | 2.9% vs 1.9% | 3.0% vs 7.8% | 12.7% vs 0.7% | |
De Ceglie et al[107], 2016 | Systematic review of 66 studies (3 RCTs; 22 prospective and 41 retrospective) | Germany, Taiwan, France, Japan, Greece, Great Britain, Czech Republic, Malaysia, Australia, Italy, China, United States, Brazil, Korea, Portugal, Serbia | 13659 patients (EMR: 8660; ESD: 4999)/17950 lesions (EMR: 11.873; ESD: 6077) | Sessile or LST | LST-NG ≥ 20 mm and for LST-G ≥ 30 mm or ≥ 40 mm | NA | 62.8% vs 90.5% | 92.0% vs 82.1% | 0.9% vs 4.8% | 2.3% vs 2.0% | NA | 10.4% (3.0% in en bloc and 12% in piecemeal) vs 1.2% |
- Citation: Shahini E, Libânio D, Lo Secco G, Pisani A, Arezzo A. Indications and outcomes of endoscopic resection for non-pedunculated colorectal lesions: A narrative review. World J Gastrointest Endosc 2021; 13(8): 275-295
- URL: https://www.wjgnet.com/1948-5190/full/v13/i8/275.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i8.275